Characteristics | No-Chemotherapy (n = 1652) |  | Chemotherapy (n = 248) |  | Total (n = 1900) |  | P c | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
No | % | No | % | No | % | ||||||
Median follow-up (months) (Interquartile Range) | 186 (164–208) |  | 102 (81–123) |  | 174 (153–195) |  |  | ||||
Race | White | 1436 | 86.9 | Â | 206 | 83.1 | Â | 1642 | 86.4 | Â | 0.196 |
Black | 143 | 8.7 | Â | 30 | 12.1 | Â | 173 | 9.1 | Â | Â | |
Other a | 73 | 4.4 | Â | 12 | 4.8 | Â | 85 | 4.5 | Â | Â | |
Marital status | Married | 1113 | 67.4 | Â | 183 | 73.8 | Â | 1296 | 68.2 | Â | 0.127 |
Not married b | 469 | 28.4 | Â | 56 | 22.6 | Â | 525 | 27.6 | Â | Â | |
Missing | 70 | 4.2 | Â | 9 | 3.6 | Â | 79 | 4.2 | Â | Â | |
Laterality | Left | 836 | 50.6 | Â | 133 | 53.6 | Â | 969 | 51.0 | Â | 0.374 |
Right | 816 | 49.4 | Â | 115 | 46.4 | Â | 931 | 49.0 | Â | Â | |
Histology | Ductal | 1275 | 77.2 | Â | 207 | 83.5 | Â | 1482 | 78.0 | Â | 0.026 |
Other d | 377 | 22.8 | Â | 41 | 16.5 | Â | 418 | 22.0 | Â | Â | |
Grade | Well | 181 | 11.0 |  | 7 | 2.8 |  | 188 | 9.9 |  | < 0.001 |
Moderately | 649 | 39.3 | Â | 103 | 41.5 | Â | 752 | 39.6 | Â | Â | |
Poorly/undifferentiated | 424 | 25.7 | Â | 100 | 40.3 | Â | 524 | 27.6 | Â | Â | |
Missing | 398 | 24.1 | Â | 38 | 15.3 | Â | 436 | 22.9 | Â | Â | |
Stage | I | 533 | 32.3 |  | 28 | 11.3 |  | 561 | 29.5 |  | < 0.001 |
II | 566 | 34.3 | Â | 107 | 43.1 | Â | 673 | 35.4 | Â | Â | |
III | 192 | 11.6 | Â | 91 | 36.7 | Â | 283 | 14.9 | Â | Â | |
Missing | 361 | 21.9 | Â | 22 | 8.9 | Â | 383 | 20.2 | Â | Â | |
Tumor size | T1 | 689 | 41.7 |  | 74 | 29.8 |  | 763 | 40.2 |  | < 0.001 |
T2 | 477 | 28.9 | Â | 117 | 47.2 | Â | 594 | 31.3 | Â | Â | |
T3/4 | 120 | 7.3 | Â | 32 | 12.9 | Â | 152 | 8.0 | Â | Â | |
Missing | 366 | 22.2 | Â | 25 | 10.1 | Â | 391 | 20.6 | Â | Â | |
Nodal status | N0 | 893 | 54.1 |  | 68 | 27.4 |  | 961 | 50.6 |  | < 0.001 |
N1 | 274 | 16.6 | Â | 82 | 33.1 | Â | 356 | 18.7 | Â | Â | |
N2/3 | 115 | 7.0 | Â | 73 | 29.4 | Â | 188 | 9.9 | Â | Â | |
Missing | 370 | 22.4 | Â | 25 | 10.1 | Â | 395 | 20.8 | Â | Â | |
Estrogen Receptor | Positive | 1047 | 63.4 |  | 197 | 79.4 |  | 1244 | 65.5 |  | < 0.001 |
Negative | 31 | 1.9 | Â | 7 | 2.8 | Â | 38 | 2.0 | Â | Â | |
Missing | 574 | 34.7 | Â | 44 | 17.7 | Â | 618 | 32.5 | Â | Â | |
Progesterone Receptor | Positive | 964 | 58.4 |  | 175 | 70.6 |  | 1139 | 59.9 |  | < 0.001 |
Negative | 100 | 6.1 | Â | 25 | 10.1 | Â | 125 | 6.6 | Â | Â | |
Missing | 588 | 35.6 | Â | 48 | 19.4 | Â | 636 | 33.5 | Â | Â | |
Surgery approach | Breast Conserving Surgery | 119 | 7.2 |  | 6 | 2.4 |  | 125 | 6.6 |  | < 0.001 |
Mastectomy | 791 | 47.9 | Â | 180 | 72.6 | Â | 971 | 51.1 | Â | Â | |
Missing | 742 | 44.9 | Â | 62 | 25.0 | Â | 804 | 42.3 | Â | Â | |
Radiation status | No | 1374 | 83.2 |  | 150 | 60.5 |  | 1524 | 80.2 |  | < 0.001 |
Yes | 278 | 16.8 | Â | 98 | 39.5 | Â | 376 | 19.8 | Â | Â |